Temple
Category: AI in Healthcare
An experimental wearable sensor device that continuously monitors cerebral blood flow in real-time, designed to measure physiological and neurological metrics that existing wearables cannot track with comparable precision. Temple was founded in 2024. The company is led by Deepinder Goyal. Based in Gurugram, India. Team size: 101-500. Total funding raised: $54.0M. Latest round: Seed. Key investors include Steadview Capital, Peak XV Partners, Vy Capital, NK Squared (Nikhil & Nithin Kamath), Deepinder Goyal (Founder), Dharana Capital, InfoEdge Ventures, Aaroh Fund.
- Founded
- 2024
- Headquarters
- Gurugram, India
- Team size
- 101-500
- Total funding
- $54.0M
Value proposition
Provides first-of-its-kind continuous, real-time brain blood flow monitoring using proxy measurements via a non-invasive temple-mounted sensor, enabling insights into cognitive performance, mental load management, and brain health that no existing wearable can deliver.
Products and solutions
Temple Wearable Sensor (temple-mounted patch device), Entropy biomarker (live 1-250 metabolic/sympathetic demand metric), Real-time Cerebral Blood Flow & Oxygenation Monitoring, Brain Health & Cognitive Performance Analytics Platform
Unique value
First wearable device to continuously and non-invasively monitor cerebral blood flow in real-time through a small sensor patch worn on the temple region. Based on proprietary 'Gravity Aging Hypothesis' - a novel theory suggesting gravity gradually reduces blood flow to the brain over a lifetime, potentially accelerating aging. Uniquely requires engineers who are also athletes with specific body fat requirements (<16% for men, <26% for women).
Target customer
Elite performance athletes (primary target), with potential future applications for students tracking focus and fatigue, older adults monitoring cognitive decline, and health-conscious individuals
Industries served
Healthcare AI, Wearable Technology, Sports Technology & Performance Analytics, Neuroscience & Brain Health, Health-tech
Technology advantage
Combines Near-Infrared Spectroscopy (NIRS) technology to estimate brain oxygenation as a proxy for cerebral blood flow, embedded AI for pattern recognition, computer vision, high-precision sensors, and brain-computer interface research. The device uses proxy measurements to monitor brain flow continuously without invasive procedures, filling a gap left by existing wearables that cannot measure these neurological metrics with comparable precision.
How they differentiate
First wearable device to continuously monitor cerebral blood flow in real-time through proxy measurements using Near-Infrared Spectroscopy (NIRS) technology. Based on proprietary 'Gravity Aging Hypothesis' - a novel theory suggesting gravity gradually reduces blood flow to the brain over a lifetime. Unlike competitors that track general fitness metrics, Temple focuses exclusively on brain health and cognitive performance monitoring with unprecedented precision. Uniquely requires engineers who are also athletes with specific body fat requirements (<16% men, <26% women).
Main competitors
WHOOP, Oura Ring, Ultrahuman
Key partnerships
Steadview Capital (Lead Investor), Peak XV Partners, NK Squared (Nikhil and Nithin Kamath), Continue Research (Longevity research venture - founded by Deepinder Goyal), Longevous (London longevity medicine practice acquired Aug 2026; continues as part of Temple), Former Zomato investors, 30+ Temple employees (participated in funding round at par valuation)
Notable customers
PV Sindhu (Olympic badminton athlete; public early user at Uber Cup / BWF World Championships 2026)
Major milestones
Raised $54M seed at $190M valuation (Feb 2026), Deepinder Goyal invested ₹104 crore personally in seed round, 30+ employees invested at par valuation, Founder stepped down as Eternal/Zomato CEO (Feb 2026), First 100 Temples ready; early-access applications opened (May 2026); 100k+ applicants reported, Entropy biomarker announced (Jun 2026), ESOP liquidity at $375M valuation (Jul 2026); targeting next round ~$500M, Device shrunk to <half prior size; limited launch pre-orders soon, ship by end-2026 (Aug 2026), Acquired London longevity practice Longevous; Mohr CMO, Roy Head of Science (Aug 2026), PV Sindhu spotted wearing Temple at Uber Cup / BWF Worlds 2026
Growth metrics
Still pre-revenue commercially; ~200-220 employees. Seed post-money $190M (Feb 2026); Jul 2026 ESOP liquidity valued company at $375M with external interest cited at ~$500M (round not closed). First 100 early-access units invited May 2026; limited launch edition pre-orders announced Aug 2026 for shipment before end-2026. Pricing reports ~Rs 75-80k / ~$1,000.
Market positioning
Premium health-tech wearable for elite athletes, executives and health-conscious users (not mass market). Moving from prototype to limited commercial launch (early access May 2026; limited edition pre-orders Aug 2026, ship by end-2026) while still validating Entropy science. Wellness positioning first; medical-device features deferred pending regulatory path. Niche between consumer wearables and clinical longevity tools.
Geographic focus
Headquartered in Gurugram, India with global athlete reach. Strong backing from India-based investors (Steadview Capital, Peak XV Partners) with deep connections to Zomato ecosystem. Founded by prominent Indian entrepreneur with international expansion potential.
Patents and IP
No registered patents disclosed publicly as of latest update
About Deepinder Goyal
Founder & CEO of Zomato (2008-Feb 2026); Vice Chairman of Eternal (Feb 2026-present); Founder of Temple (2024-present), Continue Research (2024-present), and LAT Aerospace; Management Consultant at Bain & Company (2005-2007)
Latest news about Temple
More AI in Healthcare companies
Official website: https://www.temple.com
